<i>CYP2D6</i> and <i>CYP2C8</i> pharmacogenetics and pharmacological interactions to predict imatinib plasmatic exposure in GIST patients-Reference-Cited by-同舟云学术

CYP2D6 and CYP2C8 pharmacogenetics and pharmacological interactions to predict imatinib plasmatic exposure in GIST patients

Published:2022-10-19 Issue:3 Volume:89 Page:1089-1098
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Dalle Fratte Chiara¹^ORCID,Gagno Sara¹^ORCID,Roncato Rossana¹^ORCID,Polesel Jerry²^ORCID,Zanchetta Martina¹^ORCID,Buzzo Mauro¹^ORCID,Posocco Bianca¹^ORCID,De Mattia Elena¹^ORCID,Borsatti Rachele¹,Puglisi Fabio³⁴^ORCID,Foltran Luisa³^ORCID,Guardascione Michela¹³^ORCID,Buonadonna Angela³^ORCID,Cecchin Erika¹^ORCID,Toffoli Giuseppe¹^ORCID

Affiliation:

1. Experimental and Clinical Pharmacology Centro di Riferimento Oncologico di Aviano (CRO), IRCCS Aviano Italy

2. Unit of Cancer Epidemiology Centro di Riferimento Oncologico di Aviano (CRO), IRCCS Aviano Italy

3. Department of Medical Oncology, Unit of Medical Oncology and Cancer Prevention Centro di Riferimento Oncologico di Aviano (CRO), IRCCS Aviano Italy

4. Department of Medicine University of Udine Udine Italy

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15551

Reference38 articles.

1. Imatinib Plasma Levels Are Correlated With Clinical Benefit in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors

2. Optimizing the dose in cancer patients treated with imatinib, sunitinib and pazopanib

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ultrasensitive detection of imatinib in human serum using a gold-based paper sensor;Journal of Chromatography B;2024-02

2. Clinical pharmacokinetics and Drug–drug interactions of tyrosine-kinase inhibitors in chronic myeloid leukemia: a clinical perspective;Critical Reviews in Oncology/Hematology;2024-02

3. The Status Quo of Pharmacogenomics of Tyrosine Kinase Inhibitors in Precision Oncology: A Bibliometric Analysis of the Literature;Pharmaceutics;2024-01-25

4. Therapeutic drug monitoring and pharmacogenetics to tune imatinib exposure in gastrointestinal stromal tumor patients: hurdles and perspectives for clinical implementation;Pharmacogenomics;2023-12

5. The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure;DARU Journal of Pharmaceutical Sciences;2023-06-15